
Sun Pharma ordered to halt eye drug production at Assam plant over quality
Benchmarks Nifty23,053.10116.35FEATURED FUNDS★★★★★Motilal Oswal Midcap Fund Direct-Growth5Y Return18.73 % Invest NowFEATURED FUNDS★★★★★UTI Aggressive Hybrid Fund Regular Plan-Growth5Y Return9.04 % Invest NowEnter search…
Read report ↗





